Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Director dealings: New Afentra appointee invests, Dunelm insider covers tax bill
(Sharecast News) - Two London-listed companies, Afentra and Dunelm Group, were among those reporting director and senior management share transactions on Tuesday, following recent board and market developments at both firms. Afentra, the AIM-listed upstream oil and gas company focused on West Africa, reported that Acorn Investment Management, a person closely associated with newly appointed non-executive director Andrew Osborne, purchased 225,000 ordinary shares in the company at an average price of 47.11p per share.
The transaction, valued at around £106,000, was made on 10 November.
It followed Afentra's announcement on Monday of Osborne's appointment as an independent non-executive director and chair of the audit committee.
Afentra said Osborne, a former Harbour Energy executive, was bringing more than three decades of senior leadership experience in oil and gas, capital markets, and mergers and acquisitions.
His addition to the board was welcomed by Afentra chairman Thierry Tanoh, who highlighted Osborne's "deep financial, transaction and governance experience" as enhancing the company's oversight and capital discipline.
Separately, homeware retailer Dunelm Group disclosed that group general counsel and company secretary Luisa Wright exercised 4,787 nil-cost options under the company's long-term incentive plan, and subsequently sold 2,257 shares at 1,121p each to cover tax and National Insurance liabilities arising from the exercise.
Both transactions took place on 10 November, with the sale conducted on the London Stock Exchange.
The disclosure came as Dunelm's shares recovered from a recent drop following an upgrade last week from RBC Capital Markets, which lifted its rating to "outperform" and raised its price target to 1,300p.
At the time, the bank cited stronger gross margin momentum, robust cash generation and expanding market share as reasons for its improved outlook.
RBC forecast 2026 revenue growth of just over 5%, and said it saw potential for further shareholder returns, including a special dividend early next year.
Reporting by Josh White for Sharecast.com.
Top Director Buys
Hikma Pharmaceuticals (HIK) Director name: Darwazah,Said Amount purchased: 100,000 @ 1,616.00p Value: £1,615,999.98
Hikma Pharmaceuticals (HIK) Director name: Darwazah,Said Amount purchased: 100,000 @ 1,605.00p Value: £1,604,999.92
Hikma Pharmaceuticals (HIK) Director name: Darwazah,Said Amount purchased: 100,000 @ 1,592.00p Value: £1,592,000.01
Hikma Pharmaceuticals (HIK) Director name: Darwazah,Said Amount purchased: 100,000 @ 1,525.00p Value: £1,525,000.00
Hikma Pharmaceuticals (HIK) Director name: Darwazah,Said Amount purchased: 70,000 @ 1,541.00p Value: £1,078,699.99
Hikma Pharmaceuticals (HIK) Director name: Darwazah,Said Amount purchased: 60,000 @ 1,589.00p Value: £953,400.02
Metlen Energy & Metals (MTLN) Director name: Mytilineos,Evangelos Amount purchased: 10,000 @ 42.15 Value: 421,525.00
Afentra (AET) Director name: Osborne,Andrew Amount purchased: 225,000 @ 47.11p Value: £105,995.92
Mercantile Investment Trust (the) (MRC) Director name: Beagles,Rachel Amount purchased: 30,000 @ 246.73p Value: £74,019.00
Mercantile Investment Trust (the) (MRC) Director name: Beagles,Rachel Amount purchased: 10,771 @ 247.04p Value: £26,608.45
Hays (HAS) Director name: Kirby,Anthony Amount purchased: 10,000 @ 58.28p Value: £5,827.91
F&c Investment Trust (FCIT) Director name: Smith,Rain Newton Amount purchased: 81 @ 1,217.96p Value: £986.55
F&c Investment Trust (FCIT) Director name: Hollond,Beatrice Amount purchased: 81 @ 1,217.96p Value: £986.55
Judges Scientific (JDG) Director name: Ormsby,Bradley Leonard Amount purchased: 3 @ 5,540.00p Value: £166.20
Judges Scientific (JDG) Director name: Cicurel,David Amount purchased: 3 @ 5,540.00p Value: £166.20
Taylor Wimpey (TW.) Director name: Daly,Jennie Amount purchased: 142 @ 105.49p Value: £149.80
Taylor Wimpey (TW.) Director name: Carney,Chris Amount purchased: 142 @ 105.49p Value: £149.80
Spectris (SXS) Director name: Noon,Angela Amount purchased: 3 @ 4,108.67p Value: £123.26
Spectris (SXS) Director name: Heath ,Andrew Amount purchased: 3 @ 4,108.67p Value: £123.26
Spectris (SXS) Director name: Harding ,Derek Amount purchased: 3 @ 4,108.67p Value: £123.26
Top Director Sells
Dunelm Group (DNLM) Director name: Wright,Luisa Amount sold: 2,257 @ 1,121.00p Value: £25,300.97
Staffline Group (STAF) Director name: Spain,Thomas Amount sold: 43,036 @ 45.50p Value: £19,581.38
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.